In view of the regulatory role of E3 ubiquitin ligases in UPS machinery, the dysfunction or changes in their level may propagate the disease-related aberrant processes and accelerate the AD pathology and, therefore, suggested to be a therapeutic target for the management of AD [62]. Here, PRKN is linked to Alzheimer disease.